European AIDS Clinical Society. Guidelines: Clinical management and treatment of HIV infected adults in Europe – version 6.1. European AIDS Clinical Society Web site. www.europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/eacsguidelines-v6-1_english.pdf. 2011November.
2.
Panel on Treatment of HIV-1 Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. AIDSinfo. http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf. 2011 September 14.
3.
ThompsonMA, AbergJA, CahnPet al.Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA, 2010; 304:321–333.
4.
GazzardB, BernardAJ, BoffitoMet al.British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med, 2006; 7:487–503.
5.
de RuiterA, MerceyD, AndersonJet al.British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women. HIV Med, 2008; 9:452–502.
6.
WattsDH. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med, 2002; 346:1879–1891.
7.
Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 January 2011. The Antiretroviral Pregnancy Registry Web site. www.APRegistry.com. 2011 October 5.
8.
MolinaJM, Andrade-VillaneuvaJ, EchevarriaJet al.Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. J Acquir Immune Defic Syndr, 2010; 53:323–332.
9.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. December1, 2009. Department of Health and Human Services. www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. 2011 October 14.
10.
CovingtonDL, TilsonH, ElderJet al.Assessing teratogenicity of antiretroviral drugs: Monitoring and analysis plan of the Antiretroviral Pregnancy Registry. Pharmacoepidemiol Drug Saf, 2004; 13:537–545.
11.
Centers for Disease Control and Prevention. Basic facts about birth defects: What is a birth defect?www.cdc.gov/ncbddd/birthdefects/facts.html. 2011 November 16.
12.
CovingtonDL, DoiPA, TilsonHet al.Antiretroviral Pregnancy Registry conforms with FDA Guidelines for Pregnancy Exposure Registries [abstract]Pharmacoepidemiol Drug Saf, 2003; 12,Suppl 1:S22.
